Pharmocann Global (XTAE:PMCN-M) Pre-Tax Income : ₪-17.87 Mil (TTM As of Dec. 2023)

Pharmocann Global Pre-Tax Income Chart

Pharmocann Global Annual Data
	Trend	Dec09	Dec10	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Pre-Tax Income		Get a 7-Day Free Trial					-44.49	6.06	-22.37	-24.48	-9.73

Pharmocann Global Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															-5.44	-7.50	-10.37	-	-

Competitive Comparison of Pharmocann Global's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmocann Global's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmocann Global's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmocann Global's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Pharmocann Global's Pre-Tax Income falls into.

Pharmocann Global Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Pharmocann Global's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pharmocann Global's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-17.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmocann Global  (XTAE:PMCN-M) Pre-Tax Income Explanation

Pharmocann Global's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

During the past 12 years, Pharmocann Global's highest Pretax Margin was 56.69%. The lowest was -213.07%. And the median was -61.73%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmocann Global Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Pharmocann Global's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmocann Global (XTAE:PMCN-M) Business Description